Growing community of inventors

Weesp, Netherlands

Gerrit Klein

Average Co-Inventor Count = 6.46

ph-index = 1

The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.

Forward Citations = 9

Gerrit KleinIrene Eijgendaal (3 patents)Gerrit KleinMaria J L Terhorst-Van Amstel (3 patents)Gerrit KleinKlaas Zwier (3 patents)Gerrit KleinHendrikus T Rigter (2 patents)Gerrit KleinNico Bruins (2 patents)Gerrit KleinErik Gout (2 patents)Gerrit KleinSangeeta Raje (1 patent)Gerrit KleinCaroline Boon (1 patent)Gerrit KleinEllen Bech Christensen (1 patent)Gerrit KleinMichiel H De Vries (1 patent)Gerrit KleinJeff Paul (1 patent)Gerrit KleinDorte Malling (1 patent)Gerrit KleinAnneke Winsemius (1 patent)Gerrit KleinGerrit Klein (3 patents)Irene EijgendaalIrene Eijgendaal (3 patents)Maria J L Terhorst-Van AmstelMaria J L Terhorst-Van Amstel (3 patents)Klaas ZwierKlaas Zwier (3 patents)Hendrikus T RigterHendrikus T Rigter (2 patents)Nico BruinsNico Bruins (2 patents)Erik GoutErik Gout (2 patents)Sangeeta RajeSangeeta Raje (1 patent)Caroline BoonCaroline Boon (1 patent)Ellen Bech ChristensenEllen Bech Christensen (1 patent)Michiel H De VriesMichiel H De Vries (1 patent)Jeff PaulJeff Paul (1 patent)Dorte MallingDorte Malling (1 patent)Anneke WinsemiusAnneke Winsemius (1 patent)
..
Inventor’s number of patents
..
Strength of working relationships

Company Filing History:

1. Solvay Pharmaceuticals, B.v. (2 from 67 patents)

2. Solvay Pharmaceuticals, Gmbh (1 from 77 patents)


3 patents:

1. 7964604 - Bifeprunox mesylate maintenance dose compositions and methods for using the same

2. 7435738 - Stable crystalline form of bifeprunox mesylate (7-[4-([1,1'-biphenyl]-3-ylmethyl)-1-piperazinyl]-2(3H)-benzoxazolone monomethanesulfonate)

3. 7405216 - Stable crystalline form of bifeprunox mesylate (7-[4-([1,1'-biphenyl]-3-ylmethyl)-1-piperazinyl]-2(3H)-benzoxazolone monomethanesulfonate)

Please report any incorrect information to support@idiyas.com
idiyas.com
as of
1/10/2026
Loading…